Background CPAP reduces blood pressure (BP) in patients with symptomatic obstructive
sleep apnoea (OSA). Whether the same benefit is present in patients with minimally …

Background Millions of individuals with obstructive sleep apnoea (OSA) are treated by
CPAP aimed at reducing blood pressure (BP) and thus cardiovascular risk. However …

Background CPAP is considered the therapy of choice for OSA, but the extent to which it can
reduce BP is still under debate. We undertook a systematic review and meta-analysis of …

Background: A randomised controlled study was undertaken to examine the effect of nasal
continuous positive airway pressure (CPAP) on 24 hour systemic blood pressure (BP) in …

Purpose Continuous positive airway pressure (CPAP) therapy may decrease the risk of
mortality and cardiovascular events in patients with obstructive sleep apnea. However, these …

Background: Obstructive sleep apnea (OSA) may lead to the development of hypertension
and therapy with continuous positive airway pressure (CPAP) can promote reduction in …

Background Continuous positive airway pressure (CPAP) in patients with obstructive sleep
apnea syndrome (OSAS) might lower blood pressure, but evidence from clinical studies is …

Study Objectives: We sought to perform a patient-level meta-analysis using the individual
patient data of the trials identified in our previous study-level meta-analysis investigating the …

Patients with untreated obstructive sleep apnea hypopnea (OSAH) are predisposed to
developing hypertension, and therapy with continuous positive airway pressure (CPAP) may …

Background Whether continuous positive airway pressure (CPAP) treatment can improve
depression or anxiety symptoms in obstructive sleep apnoea (OSA) patients remains …